Celestica Inc.CLSNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+38.1%
5Y CAGR+59.3%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
+38.1%/yr
vs +20.0%/yr prior
5Y CAGR
+59.3%/yr
Recent deceleration
Acceleration
+18.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202554.19%
202428.08%
202331.53%
202220.57%
202128.43%
20205.28%
2019-1.39%
20189.92%
20175.22%
20167.33%